Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck KGaA abandons Symphogen's cancer drug ahead of Phase III
Merck KGaA abandons Symphogen's cancer drug ahead of Phase III
Merck KGaA abandons Symphogen's cancer drug ahead of Phase III
Submitted by
admin
on January 29, 2015 - 9:39am
Source:
Fierce Biotech
News Tags:
Merck KGaA
Symphogen
Sym004
Headline:
Merck KGaA abandons Symphogen's cancer drug ahead of Phase III
Do Not Allow Advertisers to Use My Personal information
